(21) showed a seroconversion rate in only 20% of RA patients treated with abatacept as compared with 42% of patients on methotrexate and 53% on anti-TNF monotherapy after H1N1 influenza vaccine. This evidence concerns the gene TNF and rheumatoid arthritis.